These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1939140)

  • 1. Locating a low density lipoprotein-targeting domain of human apolipoprotein B-100 by expressing a minigene construct in transgenic mice.
    Xiong WJ; Zsigmond E; Gotto AM; Lei KY; Chan L
    J Biol Chem; 1991 Nov; 266(31):20893-8. PubMed ID: 1939140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
    Callow MJ; Stoltzfus LJ; Lawn RM; Rubin EM
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2130-4. PubMed ID: 8134359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice that overexpress mouse apolipoprotein B. Evidence that the DNA sequences controlling intestinal expression of the apolipoprotein B gene are distant from the structural gene.
    McCormick SP; Ng JK; Véniant M; Borén J; Pierotti V; Flynn LM; Grass DS; ConnollyA ; Young SG
    J Biol Chem; 1996 May; 271(20):11963-70. PubMed ID: 8662599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
    Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
    Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
    J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary structure comparison of the proposed low density lipoprotein (LDL) receptor binding domain of human and pig apolipoprotein B: implications for LDL-receptor interactions.
    Ebert DL; Maeda N; Lowe SW; Hasler-Rapacz J; Rapacz J; Attie AD
    J Lipid Res; 1988 Nov; 29(11):1501-9. PubMed ID: 3241126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice expressing full-length human apolipoprotein B-100. Full-length human apolipoprotein B mRNA is essentially not edited in mouse intestine or liver.
    Xiong W; Zsigmond E; Gotto AM; Reneker LW; Chan L
    J Biol Chem; 1992 Oct; 267(30):21412-20. PubMed ID: 1400454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
    Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).
    Linton MF; Farese RV; Chiesa G; Grass DS; Chin P; Hammer RE; Hobbs HH; Young SG
    J Clin Invest; 1993 Dec; 92(6):3029-37. PubMed ID: 8254057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
    Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
    J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
    Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S
    J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.
    Schneider M; Witztum JL; Young SG; Ludwig EH; Miller ER; Tsimikas S; Curtiss LK; Marcovina SM; Taylor JM; Lawn RM; Innerarity TL; Pitas RE
    J Lipid Res; 2005 Apr; 46(4):769-78. PubMed ID: 15654123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
    Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
    J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins.
    Broedl UC; Maugeais C; Millar JS; Jin W; Moore RE; Fuki IV; Marchadier D; Glick JM; Rader DJ
    Circ Res; 2004 Jun; 94(12):1554-61. PubMed ID: 15117821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
    Gabel BR; Koschinsky ML
    Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.
    Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells.
    Dashti N
    J Biol Chem; 1992 Apr; 267(10):7160-9. PubMed ID: 1313035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase.
    Miyake JH; Doung XD; Strauss W; Moore GL; Castellani LW; Curtiss LK; Taylor JM; Davis RA
    J Biol Chem; 2001 Jun; 276(26):23304-11. PubMed ID: 11323427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypobetalipoproteinemic mice with a targeted apolipoprotein (Apo) B-27.6-specifying mutation: in vivo evidence for an important role of amino acids 1254-1744 of ApoB in lipid transport and metabolism of the apoB-containing lipoprotein.
    Chen Z; Fitzgerald RL; Schonfeld G
    J Biol Chem; 2002 Apr; 277(16):14135-45. PubMed ID: 11839763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.